Profil
Dibang Lin is the founder of Cali Biosciences Co. Ltd.
(founded in 2021) and Shenzhen Hongbangsheng Asset Management Co. Ltd.
(founded in 2014).
He is currently the Chairman & General Manager of Cali Shenzhen Biosciences Co. Ltd., Chairman & General Manager of Liye Pharmaceutical Co. Ltd., Chief Financial Officer & Director of Cali Biosciences Us LLC, Executive Director of Shanghai Qigui Film & Television Culture Co. Ltd., Executive Director of Shanxi Liye Pharmaceutical Co. Ltd., Director of Hunan Liye Real Estate Development Co. Ltd., Director of Liye Jingcheng Real Estate Development Co. Ltd., and Director of Hubei Liye Biological Products Co. Ltd.
His former job was as Manager-Finance Department at ChinaLin Securities Co., Ltd.
from 2013 to 2014.
Aktive Positionen von Dibang Lin
| Unternehmen | Position | Beginn |
|---|---|---|
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Gründer | 17.03.2021 |
| Cali Biosciences Us LLC | Finanzdirektor/CFO | - |
| Cali Shenzhen Biosciences Co. Ltd. | Vorsitzender | - |
| Shanghai Qigui Film & Television Culture Co. Ltd. | Direktor/Vorstandsmitglied | 01.08.2017 |
| Shanxi Liye Pharmaceutical Co. Ltd. | Direktor/Vorstandsmitglied | 01.06.2017 |
| Hunan Liye Real Estate Development Co. Ltd. | Direktor/Vorstandsmitglied | 01.06.2016 |
| Liye Jingcheng Real Estate Development Co. Ltd. | Direktor/Vorstandsmitglied | 01.05.2016 |
| Hubei Liye Biological Products Co. Ltd. | Direktor/Vorstandsmitglied | 01.05.2016 |
| Liye Pharmaceutical Co. Ltd. | Vorsitzender | 01.05.2015 |
Ehemalige bekannte Positionen von Dibang Lin
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHINALIN SECURITIES CO., LTD | Finance |
| Private Unternehmen | 10 |
|---|---|
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |
| Cali Shenzhen Biosciences Co. Ltd. | |
| Cali Biosciences Us LLC | |
| Shanghai Qigui Film & Television Culture Co. Ltd. | |
| Shanxi Liye Pharmaceutical Co. Ltd. | |
| Hunan Liye Real Estate Development Co. Ltd. | |
| Liye Jingcheng Real Estate Development Co. Ltd. | |
| Hubei Liye Biological Products Co. Ltd. | |
| Liye Pharmaceutical Co. Ltd. | |
| Shenzhen Hongbangsheng Asset Management Co. Ltd. |
